Published in Int J Obes on January 01, 1979
Branched-chain amino acids in metabolic signalling and insulin resistance. Nat Rev Endocrinol (2014) 1.71
MK-801 treatment affects glycolysis in oligodendrocytes more than in astrocytes and neuronal cells: insights for schizophrenia. Front Cell Neurosci (2015) 0.83
Hypertonic hyperglycemia progresses to diabetes faster than normotonic hyperglycemia. Eur J Epidemiol (2004) 0.80
The pathogenic role of persistent milk signaling in mTORC1- and milk-microRNA-driven type 2 diabetes mellitus. Curr Diabetes Rev (2015) 0.80
Global deletion of BCATm increases expression of skeletal muscle genes associated with protein turnover. Physiol Genomics (2015) 0.75
Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients. Diabetologia (2005) 1.71
Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease. Dig Liver Dis (2007) 1.38
Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels. Mol Genet Metab (1998) 1.29
Interpretation of hyperamylasemia in diabetic coma. Clin Chem (1973) 1.28
A review of the literature of Bardet-Biedl disease and report of three cases associated with metabolic syndrome and diagnosed after the age of fifty. Obes Rev (2002) 1.16
Increased activity of some enzymes in serum in cases of severely decompensated diabetes, with and without ketoacidosis. Clin Chem (1972) 1.01
Exposure to glibenclamide increases rat beta cells sensitivity to glucose. Br J Pharmacol (2000) 0.96
A functional polymorphism of the vasoactive intestinal peptide receptor 1 gene correlates with the presence of HLA-B*2705 in Sardinia. Genes Immun (2008) 0.93
Age-dependent association of idiopathic achalasia with vasoactive intestinal peptide receptor 1 gene. Neurogastroenterol Motil (2009) 0.93
Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells. Diabetes (2000) 0.92
Glucose modulates glucose transporter affinity, glucokinase activity, and secretory response in rat pancreatic beta-cells. Diabetes (1993) 0.88
Therapeutic options for elderly diabetic subjects: open label, randomized clinical trial of insulin glargine added to oral antidiabetic drugs versus increased dosage of oral antidiabetic drugs. Acta Diabetol (2008) 0.88
Insulin sensitivity of blood glucose versus insulin sensitivity of blood free fatty acids in normal, obese, and obese-diabetic subjects. Metabolism (2001) 0.88
Serum enzymes in diabetes mellitus. Clin Chem (1973) 0.87
Fast reversibility of glucose-induced desensitization in rat pancreatic islets. Evidence for an involvement of ionic fluxes. Diabetes (1996) 0.86
Insulin resistance in obesity: metabolic mechanisms and measurement methods. Mol Genet Metab (1998) 0.86
Separate impact of metabolic syndrome and altered glucose tolerance on early markers of vascular injuries. Atherosclerosis (2012) 0.85
Effects of metformin on oxidative stress, adenine nucleotides balance, and glucose-induced insulin release impaired by chronic free fatty acids exposure in rat pancreatic islets. J Endocrinol Invest (2011) 0.84
Chronic exposure to glibenclamide impairs insulin secretion in isolated rat pancreatic islets. J Endocrinol Invest (1991) 0.83
Fatty acid synthesis from glutamate in the adipose tissue of normal subjects and obese patients: an enzyme study. Biochem Mol Med (1995) 0.83
Rheumatoid syndrome associated with lung interstitial disorder in a dental technician exposed to ceramic silica dust. A case report and critical literature review. Clin Rheumatol (2002) 0.83
A large spontaneous splenorenal shunt in a patient with liver cirrhosis and uncomplicated portal hypertension. Dig Dis (1999) 0.82
Animal and human tissue Na,K-ATPase in normal and insulin-resistant states: regulation, behaviour and interpretative hypothesis on NEFA effects. Obes Rev (2007) 0.82
Italian Consensus Conference--overweight, obesity and health. Int J Obes (1991) 0.82
Enzymes of glucose metabolism in liver of subjects with adult-onset diabetes. Diabetes (1974) 0.81
[Silicone breast prosthesis and rheumatoid arthritis: a new systemic disease: siliconosis. A case report and a critical review of the literature]. Minerva Med (1998) 0.81
Response of insulin, glucagon, lactate, and nonesterified fatty acids to glucose in visceral obesity with and without NIDDM: relationship to hypertension. Mol Genet Metab (1998) 0.81
Hypomagnesemia and smooth muscle contractility: diffuse esophageal spasm in an old female patient. Miner Electrolyte Metab (1998) 0.80
Glucose regulates both glucose transport and the glucose transporter gene expression in a hamster-derived pancreatic beta-cell line (HIT). Diabetologia (1991) 0.80
Increased serum activity of beta-n-acetyl-glucoseaminidase in atherosclerosis. Am J Med Sci (1974) 0.80
Chronic exposure to high leucine impairs glucose-induced insulin release by lowering the ATP-to-ADP ratio. Am J Physiol Endocrinol Metab (2001) 0.80
Copper addition prevents the inhibitory effects of interleukin 1-beta on rat pancreatic islets. Diabetologia (1995) 0.80
Molecular determinants of insulin resistance, cell apoptosis and lipid accumulation in non-alcoholic steatohepatitis. Nutr Metab Cardiovasc Dis (2007) 0.80
[Hyperkeratotic Kaposi sarcoma with leg lymphoedema after prolonged corticosteroid therapy for SLE. Case report and review of the literature]. Minerva Med (2001) 0.79
Serum N-acetyl-beta-glucosaminidase activity in diabetic patients. Diabetes (1972) 0.79
Serum beta-glucuronidase activity in diabetic patients as related to vascular complications and degree of glucose metabolic disorder. Am J Med Sci (1972) 0.79
Effects of prolonged glucose stimulation on pancreatic beta cells: from increased sensitivity to desensitization. Acta Diabetol (1996) 0.79
Propofol infusion and auditory evoked potentials. Anaesthesia (1988) 0.79
Metabolic effects of short-term fasting in obese hyperglycaemic humans and mice. Int J Obes (1987) 0.78
Increased beta-N-acetyl-glucosaminidase activity in diabetes mellitus. Clin Chem (1974) 0.78
Insulin sensitivity indexes calculated from oral glucose tolerance test data. Diabetes Care (2000) 0.78
Enzymes of glucose metabolism and of the citrate cleavage pathway in adipose tissue of normal and diabetic subjects. Diabetes (1975) 0.78
Metabolic effects of high glucose concentrations: inhibition of hepatic pyruvate kinase. Diabetes Res (1989) 0.77
The glucose-6-phosphatase/glucokinase ratio in the liver of obese-diabetic subjects. Biochem Med Metab Biol (1989) 0.77
Comparison of combined therapies in treatment of secondary failure to glyburide. Diabetes Care (1992) 0.77
Controlled oral glucose tolerance test: evaluation of insulin resistance with an insulin infusion algorithm that forces the OGTT glycaemic curve within the normal range. A feasibility study. Clin Physiol (1999) 0.77
Enzymes related to lipogenesis in the adipose tissue of obese subjects. Metabolism (1976) 0.77
Enzyme activities of NADPH-forming metabolic pathways in normal and leukemic leukocytes. Clin Chem (1975) 0.77
Cathepsin D and other hydrolases in the kidney of streptozotocin-diabetic mice. Possible relevance to microangiopathy. Horm Metab Res (1985) 0.77
Effects of short-term metformin treatment on insulin sensitivity of blood glucose and free fatty acids. Diabetes Obes Metab (2004) 0.77
Hypomagnesemia. A review of pathophysiological, clinical and therapeutical aspects. Panminerva Med (2001) 0.77
Anabolic response of some tissues to diabetes. Biochem Med Metab Biol (1986) 0.76
Rabbit lens and retina phosphorylate glucose through a glucokinase-like enzyme: study in normal and spontaneously hyperglycemic animals. J Diabetes Complications (1996) 0.76
Genetic deficiency of factor VII and hemorrhagic diathesis. A case report and literature review. Panminerva Med (1998) 0.76
Insulin resistance in the obese hyperglycemic (ob/ob) mouse. Failure of hyperinsulinemia to activate hepatic pyruvate kinase (PK). Metabolism (1984) 0.76
Increased hexokinase/glucose-6-phosphatase ratio in the diabetic kidney as index of glucose overutilization. Clin Physiol Biochem (1989) 0.75
Extra-pancreatic action of glibenclamide in man: reduction in vitro of the inhibitory effect of glucagon and epinephrine on the hepatic key glycolytic enzymes phosphofructokinase (PFK) and pyruvate kinase (PK). Eur J Clin Invest (1989) 0.75
[A rare case of juvenile diabetes mellitus associated with APECED (autoimmune poly-endocrinopathy, candidiasis and ectodermal dystrophy) with strong X-linked familial inheritance]. Minerva Endocrinol (1997) 0.75
[Familial Marfan's syndrome. A critical review and presentation of a clinical case]. Minerva Med (1996) 0.75
[Protein S deficiency and thrombophilia: presentation of a clinical case and review of the literature]. Ann Ital Med Int (1994) 0.75
[Diffuse symptomatic polypoid lipomatosis of the colon with hyperplasia of epiploic appendices: a case report]. Ann Ital Med Int (1995) 0.75
[Potentiating drugs in postoperative pain control with opiates for patient controlled analgesia]. Minerva Anestesiol (1988) 0.75
NADPH-forming dehydrogenases in the adipose tissue of obese and nonobese diabetics. Metabolism (1976) 0.75
[Preanesthetic medication in emergencies in newborns and children]. Minerva Anestesiol (1991) 0.75
[Extrapancreatic action of glibenclamide. Reduction of the inhibitory effect of glucagon on hepatic pyruvate kinase]. Minerva Endocrinol (1985) 0.75
Increased uropepsinogen excretion in diabetes mellitus. Clin Chem (1974) 0.75
[Total lipids, cholesterol and phospholipids in the reticulocytes]. Boll Soc Ital Biol Sper (1964) 0.75
Rabbit optic nerve phosphorylates glucose through a glucokinase-like enzyme: studies in normal and spontaneously hyperglycemic animals. Biochem Med Metab Biol (1994) 0.75
[Propofol as hypnosis inductor in a case of electric cardioversion in a 31-day-old patient]. Minerva Anestesiol (1991) 0.75
[Precordial discomfort and ECG changes of repolarization associated with hypomagnesemia in a young women following colectomy for diffuse colonic lipomatosis]. Minerva Cardioangiol (1997) 0.75
Defects in enzyme regulation versus defects in enzyme synthesis as cause of metabolic disorders. Enzyme (1980) 0.75
[Somatosensory evoked potentials in pain studies]. Minerva Anestesiol (1985) 0.75
[Acoustic and somatosensory evoked potentials in anesthesia]. Minerva Anestesiol (1985) 0.75
Different effects of glucose and glyburide on insulin secretion in rat pancreatic islets pre-exposed to interleukin-1 beta. Possible involvement of K+ and Ca2+ channels. Diabetologia (1993) 0.75
[Enzymatic aspects of the adipose tissue and hepatic tissue in obese subjects and in diabetics]. Minerva Med (1979) 0.75
[Italian Consensus Conference; overweight, obesity and health (ICC S.O.S. 1991)]. Recenti Prog Med (1991) 0.75
Enzymes of citrate-cleavage pathway in liver of subjects with adult-onset diabetes. Enzyme (1977) 0.75
[Use of an automatic blood glucose measurement system for the assessment of insulin resistance during the oral glucose tolerance test]. Minerva Endocrinol (1991) 0.75
[Urticarial vasculitis syndrome. A case report and review of the literature]. Minerva Med (1997) 0.75
Metabolic factors that affect beta-cell function and survival. Diabetes Nutr Metab (2000) 0.75
Early phase insulin secretion is increased in subjects with normal fasting glucose and metabolic syndrome: a premature feature of beta-cell dysfunction. Nutr Metab Cardiovasc Dis (2010) 0.75
[Sialic acid in the reticulocytes]. Boll Soc Ital Biol Sper (1964) 0.75